ACM
EXAS

Arlington Capital Management’s Exact Sciences EXAS Stock Holding History

Arlington Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-19,501
Closed -$1.33M – 121
2023
Q3 		$1.33M Buy
19,501
+679
+4% +$57.6K 1.39% 19
2023
Q2 		$1.77M Buy
18,822
+6,881
+58% +$537K 1.54% 17
2023
Q1 		$810K Buy
+11,941
New +$768K 0.76% 37

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Arlington Capital Management's EXAS Position: Q4 2023 in Review

Arlington Capital Management sold out of Exact Sciences (EXAS) in Q4 2023, closing a stake of 19,501 shares — an estimated $1.33M sold.

Arlington Capital Management first reported a position in EXAS in Q1 2023 and held it in 3 quarters. The position peaked at $1.77M in Q2 2023. 647 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.

  • Arlington Capital Management reported no remaining Exact Sciences position as of Q4 2023 after selling out during the quarter.
  • Arlington Capital Management sold 19,501 Exact Sciences shares in Q4 2023, an estimated $1.33M.
  • Arlington Capital Management first reported a position in Exact Sciences in Q1 2023 and held it in 3 quarters.
  • Arlington Capital Management's Exact Sciences position peaked at $1.77M in Q2 2023.
  • 647 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.

Based on Arlington Capital Management's 13F filing for Q4 2023, filed 7 Feb 2024.